[Los Angeles, 17^th June 2025] – The global medical aesthetics market, valued at USD 15.2 billion in 2023, is projected to reach USD 40.5 billion by 2035, growing at a CAGR of 9.8%, according to Clearview Market Insights.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-medical-aesthetics-market/

Key Drivers

• "Tweakment" revolution: Non-surgical facelifts (e.g., HIFU) grow at 14% CAGR.
• Male demand: 1 in 4 consumers now male, driven by body sculpting.
• Tech integration: 40% of clinics use AI for personalized treatments.

Competitive Landscape

Allergan (AbbVie) leads with a 32% share, while startups like Lumenis disrupt the market with AI tools. Galderma’s Restylane Eyelight and Merz’s Samsung partnership underscore innovation.

Regional Trends

• North America accounts for a 45% share, with the U.S. dominating the demand for Botox and fillers.
• Asia-Pacific: South Korea’s K-beauty trends drive growth (12% CAGR).

Future Milestones

• 2026: FDA approves first mRNA-based skin rejuvenation.
• 2030: 60% of treatments use AI for real-time customization.

"The future is hyper-personalized, tech-driven aesthetics," says Dr. Emily Tran, CVMI Aesthetics Lead.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369